1. Home
  2. MAT vs IMVT Comparison

MAT vs IMVT Comparison

Compare MAT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$15.76

Market Cap

5.1B

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$24.94

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAT
IMVT
Founded
1945
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
MAT
IMVT
Price
$15.76
$24.94
Analyst Decision
Buy
Buy
Analyst Count
11
9
Target Price
$20.90
$30.78
AVG Volume (30 Days)
4.9M
896.5K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.24
N/A
Revenue
$5,347,623,000.00
N/A
Revenue This Year
$5.99
N/A
Revenue Next Year
$5.05
N/A
P/E Ratio
$12.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.95
$12.72
52 Week High
$22.48
$29.25

Technical Indicators

Market Signals
Indicator
MAT
IMVT
Relative Strength Index (RSI) 32.49 40.52
Support Level $15.41 $24.63
Resistance Level $19.33 $27.71
Average True Range (ATR) 0.49 1.17
MACD 0.09 -0.30
Stochastic Oscillator 18.96 15.90

Price Performance

Historical Comparison
MAT
IMVT

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: